Ident. | Authors (with country if any) | Title |
---|
000016 |
C. P. Ford [États-Unis] | THE ROLE OF D2-AUTORECEPTORS IN REGULATING DOPAMINE NEURON ACTIVITY AND TRANSMISSION |
000035 |
YIMING XIAO [Canada] ; Pierre Jannin [France] ; Tiziano D'Albis [France] ; Nicolas Guizard [Canada] ; Claire Haegelen [France] ; Florent Lalys [France] ; Marc Verin [France] ; D. Louis Collins [Canada] | Investigation of Morphometric Variability of Subthalamic Nucleus, Red Nucleus, and Substantia Nigra in Advanced Parkinson's Disease Patients Using Automatic Segmentation and PCA-Based Analysis |
000040 |
M. Morales [États-Unis] ; D. H. Root [États-Unis] | GLUTAMATE NEURONS WITHIN THE MIDBRAIN DOPAMINE REGIONS |
000097 |
P. M. Abedi [France, Maroc] ; C. Delaville [France] ; P. De Deurwaerdere [France] ; W. Benjelloun [Maroc] ; A. Benazzouz [France] | INTRAPALLIDAL ADMINISTRATION OF 6-HYDROXYDOPAMINE MIMICS IN LARGE PART THE ELECTROPHYSIOLOGICAL AND BEHAVIORAL CONSEQUENCES OF MAJOR DOPAMINE DEPLETION IN THE RAT |
000107 |
M. Rolland [France] ; C. Carcenac [France] ; P. G. Overton [Royaume-Uni] ; M. Savasta [France] ; V. Coizet [France] | ENHANCED VISUAL RESPONSES IN THE SUPERIOR COLLICULUS AND SUBTHALAMIC NUCLEUS IN AN ANIMAL MODEL OF PARKINSON'S DISEASE |
000113 |
M. Jaber [France] ; M. Benoit-Marand [France] ; L. Prestoz [France] ; A. Gaillard [France] | Cell transplantation in the damaged adult brain |
000195 |
Stéphane Leheriey [France] ; Michael A. Sharman [France] ; Clarisse Longo Dos Santos [France] ; Raphaël Paquin [France] ; Cecile Gallea [France] | Magnetic Resonance Imaging of the Substantia Nigra in Parkinson's Disease |
000222 |
C. Delaville [France] ; S. Navailles [France] ; A. Benazzouz [France] | EFFECTS OF NORADRENALINE AND SEROTONIN DEPLETIONS ON THE NEURONAL ACTIVITY OF GLOBUS PALLIDUS AND SUBSTANTIA NIGRA PARS RETICULATA IN EXPERIMENTAL PARKINSONISM |
000295 |
Timothy P. Gilmour [États-Unis] ; Christopher A. Lieu [États-Unis] ; Mark J. Nolt [États-Unis] ; Brigitte Piallat [France] ; Milind Deogaonkar [États-Unis] ; Thyagarajan Subramanian [États-Unis] | The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys |
000296 |
Timothy P. Gilmour [États-Unis] ; Brigitte Piallat [France] ; Christopher A. Lieu [États-Unis] ; Kala Venkiteswaran [États-Unis] ; Renuka Ramachandra [États-Unis] ; Anand N. Rao [États-Unis] ; Andrew C. Petticoffer [États-Unis] ; Matthew A. Berk [États-Unis] ; Thyagarajan Subramanian [États-Unis] | The effect of striatal dopaminergic grafts on the neuronal activity in the substantia nigra pars reticulata and subthalamic nucleus in hemiparkinsonian rats |
000374 |
Charles Duyckaerts [France] ; Véronique Sazdovitch ; Danielle Seilhean | Évolution des connaissances sur le processus pathologique de la maladie de Parkinson |
000453 |
A. Beyeler [France] ; N. Kadiri [France] ; S. Navailles [France] ; M. Ben Boujema [France] ; F. Gonon [France] ; C. Le Moine [France] ; C. Gross [France] ; P. De Deurwaerdere [France] | STIMULATION OF SEROTONIN2C RECEPTORS ELICITS ABNORMAL ORAL MOVEMENTS BY ACTING ON PATHWAYS OTHER THAN THE SENSORIMOTOR ONE IN THE RAT BASAL GANGLIA |
000465 |
Kwamivi Dzahini [France] ; Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Anne Bertrand [France] ; Isabelle Detraz [France] ; Marc Savasta [France] ; Vincent Leviel [France] | Pre-synaptic glutamate-induced activation of DA release in the striatum after partial nigral lesion |
000488 |
Stephane Besnard [France] ; Michael Decressac [France] ; Pierre Denise [France] | In-vivo deep brain recordings of intranigral grafted cells in a mouse model of Parkinson's disease |
000620 |
N. Chastan [France] ; G. W. M. Westby [France] ; J. Yelnik [France] ; E. Bardinet [France] ; M. C. Do [France] ; Yves Agid [France] ; M. L. Welter [France] | Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease |
000680 |
Pierre Cesaro [France] | Neuroprotection et maladie de Parkinson |
000737 |
Dieter Scheller [Allemagne] ; Christine Stichel-Gunkel [Allemagne] ; Hermann Lübbert [Allemagne] ; Gregory Porras [France] ; Paula Ravenscroft [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France, Royaume-Uni] | Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease |
000742 |
Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France] | Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid |
000745 |
Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France] | Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse |
000748 |
Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France] | MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations |
000758 |
Christine Winter [Allemagne] ; Christoph Lemke [Allemagne] ; Reinhard Sohr [Allemagne] ; Wassilios Meissner [Allemagne, France] ; Daniel Harnack [Allemagne] ; Georg Juckel [Allemagne] ; Rudolf Morgenstern [Allemagne] ; Andreas Kupsch [Allemagne] | High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat |
000774 |
E. Y. Pioli [France] ; W. Meissner [France] ; R. Sohr [Allemagne] ; C. E. Gross [France] ; E. Bezard [France] ; B. H. Bioulac [France] | DIFFERENTIAL BEHAVIORAL EFFECTS OF PARTIAL BILATERAL LESIONS OF VENTRAL TEGMENTAL AREA OR SUBSTANTIA NIGRA PARS COMPACTA IN RATS |
000795 |
Margarete Zanardo Gomes [Brésil] ; Rita Raisman-Vozari [France] ; Elaine A. Del Bel [Brésil] | A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway |
000797 |
Stéphanie Pain [France] ; Laurence Barrier [France] ; Julie Deguil [France] ; Serge Milin [France] ; Alain Piriou [France] ; Bernard Fauconneau [France] ; Guylène Page [France] | A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats |
000846 |
Bradley A. Wallace [France, États-Unis] ; Keyoumars Ashkan [France, Royaume-Uni] ; Claire E. Heise [Australie] ; Kelly D. Foote [États-Unis] ; Napoleon Torres [France] ; John Mitrofanis [France, Australie] ; Alim-Louis Benabid [France] | Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys |
000856 |
Dieter Scheller [Allemagne] ; PIU CHAN [République populaire de Chine] ; QIN LI [Royaume-Uni] ; TAO WU [République populaire de Chine] ; RENLING ZHANG [République populaire de Chine] ; LE GUAN [République populaire de Chine] ; Paula Ravenscroft [Royaume-Uni] ; Celine Guigoni [France] ; Alan R. Crossman [Royaume-Uni] ; Michael Hill [Royaume-Uni] ; Erwan Bezard [France] | Rotigotine treatment partially protects from MPTP toxicity in a progressive macaque model of Parkinson's disease |
000860 |
Vincent Paille [France] ; Vincent Henry [France] ; Laurent Lescaudron [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias |
000867 |
Duong P. Huynh [États-Unis] ; Dung T. Nguyen [États-Unis] ; Johannes B. Pulst-Korenberg [États-Unis] ; Alexis Brice [France] ; Stefan-M. Pulst [États-Unis] | Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death |
000896 |
S. Breit [France, Allemagne] ; R. Bouali-Benazzouz [France] ; R. C. Popa [Allemagne] ; T. Gasser [Allemagne] ; A. L. Benabid [France] ; A. Benazzouz [France] | Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat |
000999 |
M. Ulla [France] ; S. Thobois [France] ; J.-J. Lemaire [France] ; A. Schmitt [France] ; P. Derost [France] ; E. Broussolle [France] ; P.-M. Llorca [France] ; F. Durif [France] | Manic behaviour induced by deep-brain stimulation in Parkinson's disease : evidence of substantia nigra implication? |
000A88 |
Giinter U. Höglinger [France, Allemagne] ; Annie Lannuzel [France] ; Myriam Escobar Khondiker [France, Allemagne] ; Patrick P. Michel [France] ; Charles Duyckaerts [France] ; Jean Feger [France] ; Pierre Champy [France] ; Annick Prigent [France] ; Fadia Medja [France] ; Anne Lombes [France] ; Wolfgang H. Oertel [Allemagne] ; Merle Ruberg [France] ; Etienne C. Hirsch [France] | The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy |
000B31 |
Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France] | Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus |
000C15 |
Vincent Paille [France] ; Philippe Brachet [France] ; Philippe Damier [France] | Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease |
000C29 |
P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France] | MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration |
000C46 |
Carlos Barcia [Espagne] ; Angel Sanchez Bahillo [Espagne] ; Emiliano Fernandez-Villalba [Espagne] ; Victor Bautista [Espagne] ; Maximo Poza Y. Poza [Espagne] ; Andrés Fernandez-Barreiro [Espagne] ; Etienne C. Hirsch [France] ; Maria-Trinidad Herrero [Espagne] | Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure |
000C68 |
Elsa Y. Pioli [France] ; Sandra Dovero [France] ; Bernard H. Bioulac [France] ; Christian E. Gross [France] ; Erwan Bezard [France] | Asymmetrically lesioned mesencephalon in healthy rodents: call for caution |
000D09 |
B. Dubois [France] ; R. Beato [France] ; J.-M. Villalpando [France] | L'évaluation neuropsychologique peut contribuer au diagnostic des maladies du mouvement |
000D51 |
Christian E. Gross [France] ; Paula Ravenscroft [France] ; Sandra Dovero [France] ; Mohamed Jaber [France] ; Bernard Bioulac [France] ; Erwan Bezard [France] | Pattern of levodopa-induced striatal changes is different in normal and MPTP-lesioned mice |
000D57 |
Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France] | Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole |
000D90 |
Günter U. Höglinger [France] ; Géraldine Carrard [France] ; Patrick P. Michel [France] ; Fadia Medja [France] ; Anne Lombes [France] ; Merle Ruberg [France] ; Bertrand Friguet [France] ; Etienne C. Hirsch [France] | Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease |
000D99 |
Karine Parain [France] ; Céline Hapdey [France] ; Estelle Rousselet [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne C. Hirsch [France] | Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin |
000E09 |
Carine Cleren [France] ; Bertrand Naudin [France] ; Jean Costentin [France] | Apparent opposite effects of tetrabenazine and reserpine on the toxic effects of 1-methyl-4-phenylpyridinium or 6-hydroxydopamine on nigro-striatal dopaminergic neurons |
000E93 |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Lucette Garreau [France] ; Denis Guilloteau [France] ; Bernard Fauconneau [France] ; Sylvie Chalon [France] | Relevance of different striatal markers in assessment of the MPP+-induced dopaminergic nigrostriatal injury in rat |
000E97 |
Stéphanie Barc [France] ; Guylène Page [France] ; Laurence Barrier [France] ; Francois Huguet [France] ; Bernard Fauconneau [France] | Progressive alteration of neuronal dopamine transporter activity in a rat injured by an intranigral injection of MPP+ |
000F14 |
Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France] | Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine |
000F36 |
K. L. Double [Australie] ; D. Ben-Shachar [Israël] ; M. B. H. Youdim [Israël] ; L. Zecca [Italie] ; P. Riederer [Allemagne] ; M. Gerlach [Allemagne] | Influence of neuromelanin on oxidative pathways within the human substantia nigra |
000F46 |
I. Ghorayeb [France] ; P. O. Fernagut [France] ; N. Stefanova [Autriche] ; G. K. Wenning [Autriche] ; B. Bioulac [France] ; F. Tison [France] | Dystonia is predictive of subsequent altered dopaminergic responsiveness in a chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine + 3-nitropropionic acid model of striatonigral degeneration in monkeys |
000F51 |
Diego Centonze [Italie] ; Alessandro Usiello [France] ; Paolo Gubellini [Italie] ; Antonio Pisani [Italie] ; Emiliana Borrelli [France] ; Giorgio Bernardi [Italie] ; Paolo Calabresi [Italie] | Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors |
001043 |
Karine Parain [France] ; Véronique Marchand [France] ; Bernard Dumery [France] ; Etienne Hirsch [France] | Nicotine, but not cotinine, partially protects dopaminergic neurons against MPTP-induced degeneration in mice |
001049 |
Laurent Groc [États-Unis, France] ; Laurent Bezin [États-Unis, France] ; Jane A. Foster [États-Unis] ; HAO JIANG [États-Unis] ; Tangella S. Jackson [États-Unis] ; Dinah Weissmann [France] ; Robert A. Levine [États-Unis] | Lipid peroxidation-mediated oxidative stress and dopamine neuronal apoptosis in the substantia nigra during development |
001051 |
Carine Fillebeen [France] ; Marie-Magdeleine Ruchoux [France] ; Valérie Mitchell [France] ; Sylvie Vincent [France] ; Monique Benaïssa [France] ; Annick Pierce [France] | Lactoferrin is synthesized by activated microglia in the human substantia nigra and its synthesis by the human microglial CHME cell line is upregulated by tumor necrosis factor a or 1-methyl-4-phenylpyridinium treatment |
001062 |
Christine Dentresangle [France] ; Marion Le Cavorsin [France] ; Marc Savasta [France] ; Vincent Leviel [France] | Increased extracellular DA and normal evoked DA release in the rat striatum after a partial lesion of the substantia nigra |
001081 |
Adrian Newman-Tancredi [France] ; Didier Cussac [France] ; Mauricette Brocco [France] ; Jean-Michel Rivet [France] ; Christine Chaput [France] ; Manuelle Touzard [France] ; Valérie Pasteau [France] ; Mark J. Millan [France] | Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigra |
001171 |
E. Aliaga [Chili] ; C. Carcamo [Chili] ; J. Abarca [Chili] ; L. Tapia-Arancibia [France] ; G. Bustos [Chili] | Transient increase of brain derived neurotrophic factor mRNA expression in substantia nigra reticulata after partial lesion of the nigrostriatal dopaminergic pathway |
001177 |
M. G. Murer [France, Argentine] ; G. Dziewczapolski [Argentine] ; P. Salin [France] ; M. Vila [France] ; K. Y. Tseng [Argentine] ; M. Ruberg [France] ; M. Rubinstein [Argentine] ; M. A. Kelly [États-Unis] ; D. K. Grandy [États-Unis] ; M. J. Low [États-Unis] ; E. Hirsch [France] ; R. Raisman-Vozari [France] ; O. Gershanik [Argentine] | The indirect basal ganglia pathway in dopamine D2 receptor-deficient mice |
001192 |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
001204 |
C. Perier [France] ; Yves Agid [France] ; E. C. Hirsch [France] ; J. Feger [France] | Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion |
001223 |
A. Benazzouz [France, République populaire de Chine] ; D. M. Gao [République populaire de Chine] ; Z. G. Ni [France] ; B. Piallat [France] ; R. Bouali-Benazzouz [France] ; A. L. Benabid [France] | Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat |
001237 |
A. Nicotra [Italie] ; S. H. Parvez [France] | Cell death induced by MPTP, a substrate for monoamine oxidase B |
001241 |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihito Akao [Japon] ; JIN ZHANG [Japon] ; Hasan Parvez [France] | Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons |
001294 |
P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis] | The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease |
001295 |
P. Damier [France, États-Unis] ; E. C. Hirsch [France] ; Yves Agid [France] ; A. M. Graybiel [États-Unis] | The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry |
001307 |
K. Parain [France] ; M. G. Murer [France] ; QIAO YAN [États-Unis] ; B. Faucheux [France] ; Yves Agid [France] ; E. Hirsch [France] ; R. Raisman-Vozari [France] | Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra |
001331 |
R. J. Ferrante [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] | Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase |
001332 |
M. G. Murer [Argentine] ; J. Ferrario [Argentine] ; M. Delfino [Argentine] ; G. Dziewczapolski [Argentine] ; O. S. Gershanik [Argentine] ; R. Raisman-Vozari [France] | Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions |
001363 |
A. Sanchez-Capelo [France] ; O. Corti [France] ; J. Mallet [France] | Adenovirus-mediated over-expression of TGFβ1 in the striatum decreases dopaminergic cell survival in embryonic nigral grafts |
001372 |
J. A. Aguirre [Espagne] ; A. Cintra [Suède] ; J. Hillion [Suède] ; J. A. Narvaez [Espagne] ; A. Jansson [Suède] ; T. Antonelli [Italie] ; L. Ferraro [Italie] ; F. A. Rambert [France] ; K. Fuxe [Suède] | A stereological study on the neuroprotective actions of acute Modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse |
001395 |
B. A. Faucheux [France] ; E. C. Hirsch [France] | Homéostasie du fer et maladie de Parkinson |
001408 |
S. Benisty [France] ; F. Boissiere [France] ; B. Faucheux [France] ; Yves Agid [France] ; E. C. Hirsch [France] | trkB messenger RNA expression in normal human brain and in the substantia nigra of parkinsonian patients : An in situ hybridization study |
001445 |
L. Vercueil [France] ; A. Benazzouz [France] ; C. Deransart [France] ; K. Bressand [France] ; C. Marescaux [France] ; A. Depaulis [France] ; A. L. Benabid [France] | High-frequency stimulation of the sub-thalamic nucleus suppresses absence seizures in the rat : comparison with neurotoxic lesions |
001446 |
E. Bezard [France] ; B. Bioulac [France] ; C. E. Gross [France] | Glutamatergic compensatory mechanisms in experimental parkinsonism |
001458 |
A. Nicole [France] ; D. Santiard-Baron [France] ; I. Ceballos-Picot [France] | Direct evidence for glutathione as mediator of apoptosis in neuronal cells : Dossier "Apoptosis Part II" |
001470 |
| Toxicité du glutamate sur des cultures primaires de neurones mésencéphaliques de la substance noire |
001474 |
| CONTRÔLE DE L'EXCITABILITÉ DES NEURONES DOPAMINERGIQUES DE LA SUBSTANCE NOIRE COMPACTE DE RAT PAR LES CATÉCHOLAMINES ET LES NEUROPEPTIDES |
001547 |
B. A. Faucheux [France] ; J. J. Hauw [France] ; Yves Agid [France] ; E. C. Hirsch [France] | The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease |
001558 |
E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France] | Presymptomatic revelation of experimental Parkinsonism |
001569 |
E. Bezard [France] ; S. Dovero [France] ; B. Bioulac [France] ; C. E. Gross [France] | Kinetics of nigral degeneration in a chronic model of MPTP-treated mice |
001570 |
M. Ruberg [France] ; B. Brugg [France] ; A. Prigent [France] ; E. Hirsch [France] ; A. Brice [France] ; Yves Agid [France] | Is differential regulation of mitochondrial transcripts in Parkinson's disease related to apoptosis? |
001585 |
E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France] | Compensatory effects of glutamatergic inputs to the substantia nigra pars compacta in experimental parkinsonism |
001608 |
| SYSTEME DOPAMINERGIQUE NIGRO-STRIATAL : Etude des récepteurs D1 et des transporteurs de l'amine |
001644 |
M. Vila [France] ; R. Levy [France] ; M.-T. Herrero ; B. Faucheux [France] ; J. A. Obeso [France] ; Yves Agid [France] ; E. C. Hirsch | Metabolic activity of the basal ganglia in Parkinsonian syndrome in human and non-human primates : A cytochrome oxidase histochemistry study |
001647 |
O.-K. Hassani [France] ; M. Mouroux [France] ; J. Feger [France] | Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus |
001648 |
A. Mouatt-Prigent [France] ; J. O. Karlsson ; Yves Agid [France] ; E. C. Hirsch [France] | Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon : A role in nerve cell death ? |
001655 |
C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area |
001657 |
V. Blanchard [France] ; P. Anglade [France] ; G. Dziewczapolski ; M. Savasta [France] ; Yves Agid [France] ; R. Raisman-Vozari [France] | Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra |
001707 |
ABDELHAMID BENAZZOUZ [France] ; B. Piallat ; P. Pollak ; A.-L. Benabid | Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats : electrophysiological data |
001708 |
F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease : a postmortem study using tritiated tetrabenazine |
001716 |
B. Pillon [France] ; N. Gouider-Khouja ; B. Deweer ; M. Vidailhet ; C. Malapani ; B. Dubois ; Yves Agid [France] | Neuropsychological pattern of striatonigral degeneration : comparison with Parkinson's disease and progressive supranuclear palsy |
001800 |
G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France] | Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease |
001808 |
A. Kastner [France] ; M. T. Herrero [France] ; E. C. Hirsch [France] ; J. Guillen ; M. R. Luquin ; F. Javoy-Agid [France] ; J. A. Obeso ; Yves Agid [France] | Decreased tyrosine hydroxylase content in the dopaminergic neurons of MPTP-intoxicated monkeys : effect of levodopa and GM1 ganglioside therpay |
001859 |
I. Marey-Semper [France] ; M. Gelman ; M. Levi-Strauss | The high sensitivity to rotenone of striatal dopamine uptake suggests the existence of a constitutive metabolic deficiency in dopaminergic neurons from the substantia nigra |
001863 |
P. Gaspar [France] ; A. Febvret [France] ; J. Colombo | Serotonergic sprouting in primate MTP-induced hemiparkinsonism |
001943 |
E. C. Hirsche [France] | Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease ? |
001953 |
A. Benazzouz [France] ; C. Gross ; J. Dupont [France] ; B. Bioulac | MPTP induced hemiparkinsonism in monkeys : behavioral, mechanographic, electromyographic and immunohistochemical studies |
001954 |
A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France] | Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ? |
001959 |
P. R. Hof [États-Unis] ; A. Charpiot ; A. Delacourte [France] ; L. Buee ; D. Purohit ; D. P. Perl ; C. Bouras | Distribution of neurofibrillary tangles and senile plaques in the cerebral cortex in postencephalitic parkinsonism |
001A09 |
E. C. Hirsch [France] ; J.-P. Brandel ; P. Galle ; F. Javoy-Agid ; Yves Agid [France] | Iron and aluminium increase in the substantia nigra of patients with Parkinson's disease : an X-ray microanalysis |
001A11 |
M. Mavridis [France] ; A.-D. Degryse ; A. J. Lategan ; M. R. Marien ; F. C. Colpaert | Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tretrahydropyridine in monkeys : a possible role for the locus coeruleus in the progression of Parkinson's disease |
001A49 |
S. Dumas ; F. Javoy-Agid ; E. Hirsch ; Yves Agid [France] ; J. Mallet | Tyrosine hydroxylase gene expression in human ventral mesencephalon : detection of tyrosine hydroxylase messenger RNA in neurites |
001A57 |
F. Javoy-Agid ; E. C. Hirsch ; S. Dumas ; C. Duyckaerts ; J. Mallet ; Yves Agid [France] | Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease : an in situ hybridization study |
001A58 |
D. T. Dexter [Royaume-Uni] ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Yves Agid [France] ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. Marsden | Decreased ferritin levels in brain in Parkinson's disease |
001A61 |
S. Malessa ; E. C. Hirsch ; P. Cervera ; C. Duyckaerts ; Yves Agid [France] | Catecholaminergic systems in the medulla oblongata in parkinsonian syndromes : a quantitative immunohistochemical study in Parkinson's disease, progressive supranuclear palsy, and striatonigral degeneration |
001C04 |
C. Llorens-Cortes ; F. Javoy-Agid ; Yves Agid [France] ; H. Taquet ; J. C. Schwartz | Enkephalinergic markers in substantia nigra and caudate nucleus from Parkinsonian subjects |